Table 1.
Outcome parameters of various studies
| Study | Type of study | Age group | Study groups and number | Efficacy for seizure control |
|---|---|---|---|---|
| Nicholas et al. (2009) | Retrospective study | 1-14 years | Levetiracetam group (n=10) | Levetiracetam (73%) |
| Unalp et al. (2014) | Retrospective study | 1 month-18 years | Levetiracetam group (n=133) | Levetiracetam (78%) |
| Satishchandra et al. (2015) | Prospective, randomized controlled | Not available | Levetiracetam, phenytoin, valproate (n=150) | Levetiracetam (78%) Phenytoin (68%) Valproate (68%) |
| Visudtibhan et al. (2015) | Retrospective study | Less than 18 years | Levetiracetam group (n=50) | Levetiracetam (60%) |
| Singh et al. (2015) | Randomized controlled trial | Not available | Levetiracetam and phenytoin groups (n=144) | Levetiracetam (59.1%) Phenytoin (68.2%) |
| Altunbasak et al. (2016) | Retrospective study | 1-192 months | Levetiracetam group (n=108) | Levetiracetam (73.1%) |
| Isgueder et al. (2016) | Retrospective study | Not available | Levetiracetam group (n=133) | Levetiracetam (78.2%) |
| This study (2017) | Randomized controlled trial | 1 month-12 years | Levetiracetam and phenytoin groups (n=104) | Levetiracetam (96.2%) Phenytoin (59.6%) |